Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Abciximab> ?p ?o }
- Abciximab abstract "Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.While abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 96 to 120 hours after discontinuation of the drug.(Tanguay, J.F., Eur Heart J 1999; 1 (suppl E): E27-E35Abciximab is made from the Fab fragments of an immunoglobulin that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.".
- Abciximab atcPrefix "B01".
- Abciximab atcSuffix "AC13".
- Abciximab casNumber "143653-53-6".
- Abciximab drugbank "DB00054".
- Abciximab fdaUniiCode "X85G7936GV".
- Abciximab wikiPageExternalLink www.reopro.com.
- Abciximab wikiPageID "771784".
- Abciximab wikiPageLength "6140".
- Abciximab wikiPageOutDegree "22".
- Abciximab wikiPageRevisionID "678341280".
- Abciximab wikiPageWikiLink (US).
- Abciximab wikiPageWikiLink Angioplasty.
- Abciximab wikiPageWikiLink Antibody.
- Abciximab wikiPageWikiLink Antiplatelet_drug.
- Abciximab wikiPageWikiLink Bleeding.
- Abciximab wikiPageWikiLink Blood_clot.
- Abciximab wikiPageWikiLink CD41.
- Abciximab wikiPageWikiLink IIIa_inhibitors.
- Abciximab wikiPageWikiLink Category:Janssen_Biotech.
- Abciximab wikiPageWikiLink Category:Monoclonal_antibodies.
- Abciximab wikiPageWikiLink Coronary_artery.
- Abciximab wikiPageWikiLink Coronary_circulation.
- Abciximab wikiPageWikiLink Eli_Lilly_and_Company.
- Abciximab wikiPageWikiLink Fragment_antigen-binding.
- Abciximab wikiPageWikiLink Fragment_antigen_binding.
- Abciximab wikiPageWikiLink IIIa.
- Abciximab wikiPageWikiLink IIIa_inhibitor.
- Abciximab wikiPageWikiLink IIIa_inhibitors.
- Abciximab wikiPageWikiLink Half-life.
- Abciximab wikiPageWikiLink Hemorrhage.
- Abciximab wikiPageWikiLink ITGA2B.
- Abciximab wikiPageWikiLink Immunoglobulin.
- Abciximab wikiPageWikiLink Intravenous.
- Abciximab wikiPageWikiLink Intravenous_therapy.
- Abciximab wikiPageWikiLink Janssen_Biologics_BV.
- Abciximab wikiPageWikiLink Platelet.
- Abciximab wikiPageWikiLink Platelet_aggregation_inhibitor.
- Abciximab wikiPageWikiLink Thrombocytopenia.
- Abciximab wikiPageWikiLink Thrombus.
- Abciximab wikiPageWikiLink United_States.
- Abciximab wikiPageWikiLinkText "Abciximab".
- Abciximab wikiPageWikiLinkText "ReoPro".
- Abciximab wikiPageWikiLinkText "abci-''xi''-mab".
- Abciximab wikiPageWikiLinkText "abciximab".
- Abciximab atcPrefix "B01".
- Abciximab atcSuffix "AC13".
- Abciximab c "2101".
- Abciximab casNumber "143653".
- Abciximab chembl "1201584".
- Abciximab chemspiderid "NA".
- Abciximab drugbank "DB00054".
- Abciximab h "3229".
- Abciximab hasPhotoCollection Abciximab.
- Abciximab kegg "D02778".
- Abciximab legalUk "POM".
- Abciximab mabType "Fab".
- Abciximab molecularWeight "47455.4".
- Abciximab n "551".
- Abciximab o "673".
- Abciximab pregnancyCategory "C (US)".
- Abciximab routesOfAdministration Intravenous.
- Abciximab routesOfAdministration Intravenous_therapy.
- Abciximab s "15".
- Abciximab source "xi/o".
- Abciximab target "CD41 7E3".
- Abciximab tradename "Reopro".
- Abciximab type "mab".
- Abciximab unii "X85G7936GV".
- Abciximab verifiedfields "changed".
- Abciximab verifiedrevid "477237058".
- Abciximab wikiPageUsesTemplate Template:Antithrombotics.
- Abciximab wikiPageUsesTemplate Template:Drugbox.
- Abciximab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Abciximab subject IIIa_inhibitors.
- Abciximab subject Category:Janssen_Biotech.
- Abciximab subject Category:Monoclonal_antibodies.
- Abciximab hypernym Inhibitor.
- Abciximab type Article.
- Abciximab type ChemicalSubstance.
- Abciximab type Company.
- Abciximab type Drug.
- Abciximab type Antibody.
- Abciximab type Article.
- Abciximab type Chemical.
- Abciximab type Company.
- Abciximab type Drug.
- Abciximab type ChemicalObject.
- Abciximab type Thing.
- Abciximab type Q8386.
- Abciximab comment "Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery.".
- Abciximab label "Abciximab".
- Abciximab sameAs أبسيكسيماب.
- Abciximab sameAs Abciximab.
- Abciximab sameAs Abciximab.
- Abciximab sameAs Abciximab.
- Abciximab sameAs Abciximab.
- Abciximab sameAs Abcyksymab.
- Abciximab sameAs Abciximab.
- Abciximab sameAs m.03b6c9.